MYO 201

N/A

Report date: 2026/05/26 20:00:28

Base Information

Drug NameMYO 201
Drug Alias NameMYO201AAVrh.74.MHCK7.DYSFAAVrh-74-MHCK7-DYSFMYO-201SRP-6004
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsDysferlin
Therapy Area/IndicationsMuscular Dystrophies, Limb-Girdle
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNationwide Children'S HospitalMyonexus Therapeutics IncSarepta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMyonexus Therapeutics IncNationwide Children'S Hospital
Inactive CompaniesSarepta Therapeutics Inc
Active IndicationsMuscular Dystrophies, Limb-Girdle
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A